APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adapalene Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Adapalene Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025194 pages

Choose your research edition.

Industry ResearchAdapalene Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Adapalene Drugs Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Adapalene Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adapalene Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Adapalene Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Adapalene Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adapalene Drugs include Wuhan Nuoan Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Jiangsu Fubang Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, HEC Pharm, Beijing Foyou Pharmaceutical, Taro Pharmaceutical, Sandoz and Glenmark, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Adapalene Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Adapalene Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Adapalene Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Adapalene Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Adapalene Drugs Segment by Company

Wuhan Nuoan Pharmaceutical

Sichuan Med-Shine Pharmaceutical

Jiangsu Fubang Pharmaceutical

Heilongjiang Fuhe Pharmaceutical

HEC Pharm

Beijing Foyou Pharmaceutical

Taro Pharmaceutical

Sandoz

Glenmark

Galderma

Encube Ethicals

Bausch Health

Alembic

Actavis

Adapalene Drugs Segment by Type

Gel

Solution

Cream

Others

Adapalene Drugs Segment by Application

Acne

Keratosis Pilaris

Others

Adapalene Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adapalene Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adapalene Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adapalene Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Adapalene Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adapalene Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Adapalene Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Adapalene Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Adapalene Drugs Industry Trends Table 2. Adapalene Drugs Industry Drivers Table 3. Adapalene Drugs Industry Opportunities and Challenges Table 4. Adapalene Drugs Industry Restraints Table 5. Global Adapalene Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Adapalene Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Adapalene Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Adapalene Drugs Sales Market Share by Manufacturers Table 9. Global Adapalene Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Adapalene Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Adapalene Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Adapalene Drugs Manufacturers, Product Type & Application Table 13. Global Adapalene Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Adapalene Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gel Table 17. Major Manufacturers of Solution Table 18. Major Manufacturers of Cream Table 19. Major Manufacturers of Others Table 20. Global Adapalene Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Adapalene Drugs Sales by Type (2021-2026) & (K Units) Table 22. Global Adapalene Drugs Sales by Type (2027-2032) & (K Units) Table 23. Global Adapalene Drugs Sales Market Share by Type (2021-2026) Table 24. Global Adapalene Drugs Sales Market Share by Type (2027-2032) Table 25. Global Adapalene Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Adapalene Drugs Revenue by Type (2021-2026) & (K Units) Table 27. Global Adapalene Drugs Revenue by Type (2027-2032) & (K Units) Table 28. Global Adapalene Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Adapalene Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Acne Table 31. Major Manufacturers of Keratosis Pilaris Table 32. Major Manufacturers of Others Table 33. Global Adapalene Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Adapalene Drugs Sales by Application (2021-2026) & (K Units) Table 35. Global Adapalene Drugs Sales by Application (2027-2032) & (K Units) Table 36. Global Adapalene Drugs Sales Market Share by Application (2021-2026) Table 37. Global Adapalene Drugs Sales Market Share by Application (2027-2032) Table 38. Global Adapalene Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Adapalene Drugs Revenue by Application (2021-2026) & (K Units) Table 40. Global Adapalene Drugs Revenue by Application (2027-2032) & (K Units) Table 41. Global Adapalene Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Adapalene Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Adapalene Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Adapalene Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Adapalene Drugs Sales Market Share by Region (2021-2026) Table 46. Global Adapalene Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Adapalene Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 50. North America Adapalene Drugs Sales by Country (2027-2032) & (K Units) Table 51. Europe Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 53. Europe Adapalene Drugs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Adapalene Drugs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Adapalene Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Adapalene Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Adapalene Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Adapalene Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Adapalene Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Adapalene Drugs Revenue Market Share by Region (2027-2032) Table 65. Wuhan Nuoan Pharmaceutical Company Information Table 66. Wuhan Nuoan Pharmaceutical Business Overview Table 67. Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Wuhan Nuoan Pharmaceutical Adapalene Drugs Product Portfolio Table 69. Wuhan Nuoan Pharmaceutical Recent Development Table 70. Sichuan Med-Shine Pharmaceutical Company Information Table 71. Sichuan Med-Shine Pharmaceutical Business Overview Table 72. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product Portfolio Table 74. Sichuan Med-Shine Pharmaceutical Recent Development Table 75. Jiangsu Fubang Pharmaceutical Company Information Table 76. Jiangsu Fubang Pharmaceutical Business Overview Table 77. Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Jiangsu Fubang Pharmaceutical Adapalene Drugs Product Portfolio Table 79. Jiangsu Fubang Pharmaceutical Recent Development Table 80. Heilongjiang Fuhe Pharmaceutical Company Information Table 81. Heilongjiang Fuhe Pharmaceutical Business Overview Table 82. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product Portfolio Table 84. Heilongjiang Fuhe Pharmaceutical Recent Development Table 85. HEC Pharm Company Information Table 86. HEC Pharm Business Overview Table 87. HEC Pharm Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. HEC Pharm Adapalene Drugs Product Portfolio Table 89. HEC Pharm Recent Development Table 90. Beijing Foyou Pharmaceutical Company Information Table 91. Beijing Foyou Pharmaceutical Business Overview Table 92. Beijing Foyou Pharmaceutical Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Beijing Foyou Pharmaceutical Adapalene Drugs Product Portfolio Table 94. Beijing Foyou Pharmaceutical Recent Development Table 95. Taro Pharmaceutical Company Information Table 96. Taro Pharmaceutical Business Overview Table 97. Taro Pharmaceutical Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Taro Pharmaceutical Adapalene Drugs Product Portfolio Table 99. Taro Pharmaceutical Recent Development Table 100. Sandoz Company Information Table 101. Sandoz Business Overview Table 102. Sandoz Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sandoz Adapalene Drugs Product Portfolio Table 104. Sandoz Recent Development Table 105. Glenmark Company Information Table 106. Glenmark Business Overview Table 107. Glenmark Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Glenmark Adapalene Drugs Product Portfolio Table 109. Glenmark Recent Development Table 110. Galderma Company Information Table 111. Galderma Business Overview Table 112. Galderma Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Galderma Adapalene Drugs Product Portfolio Table 114. Galderma Recent Development Table 115. Encube Ethicals Company Information Table 116. Encube Ethicals Business Overview Table 117. Encube Ethicals Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Encube Ethicals Adapalene Drugs Product Portfolio Table 119. Encube Ethicals Recent Development Table 120. Bausch Health Company Information Table 121. Bausch Health Business Overview Table 122. Bausch Health Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Bausch Health Adapalene Drugs Product Portfolio Table 124. Bausch Health Recent Development Table 125. Alembic Company Information Table 126. Alembic Business Overview Table 127. Alembic Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Alembic Adapalene Drugs Product Portfolio Table 129. Alembic Recent Development Table 130. Actavis Company Information Table 131. Actavis Business Overview Table 132. Actavis Adapalene Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Actavis Adapalene Drugs Product Portfolio Table 134. Actavis Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Adapalene Drugs Distributors List Table 138. Adapalene Drugs Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Adapalene Drugs Product Image Figure 2. Global Adapalene Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adapalene Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Adapalene Drugs Sales (2021-2032) & (K Units) Figure 5. Global Adapalene Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Adapalene Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gel Image Figure 9. Solution Image Figure 10. Cream Image Figure 11. Others Image Figure 12. Global Adapalene Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Adapalene Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Adapalene Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Adapalene Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Adapalene Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Adapalene Drugs Revenue Market Share by Type (2021-2032) Figure 18. Acne Image Figure 19. Keratosis Pilaris Image Figure 20. Others Image Figure 21. Global Adapalene Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Adapalene Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Adapalene Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Adapalene Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Adapalene Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Adapalene Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Adapalene Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Adapalene Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Adapalene Drugs Sales Market Share by Country (2021-2032) Figure 41. China Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Adapalene Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Adapalene Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Adapalene Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Adapalene Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Adapalene Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Adapalene Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Adapalene Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Adapalene Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Adapalene Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Adapalene Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Gel
  • Solution
  • Cream
  • Others
Applications
  • Acne
  • Keratosis Pilaris
  • Others
Companies covered
  • Wuhan Nuoan Pharmaceutical
  • Sichuan Med-Shine Pharmaceutical
  • Jiangsu Fubang Pharmaceutical
  • Heilongjiang Fuhe Pharmaceutical
  • HEC Pharm
  • Beijing Foyou Pharmaceutical
  • Taro Pharmaceutical
  • Sandoz
  • Glenmark
  • Galderma
  • Encube Ethicals
  • Bausch Health
  • Alembic
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Adapalene Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Adapalene Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Adapalene Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Adapalene Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Adapalene Drugs Market Dynamics
  1. 2.1 Adapalene Drugs Industry Trends
  2. 2.2 Adapalene Drugs Industry Drivers
  3. 2.3 Adapalene Drugs Industry Opportunities and Challenges
  4. 2.4 Adapalene Drugs Industry Restraints
3 Adapalene Drugs Market by Manufacturers
  1. 3.1 Global Adapalene Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Adapalene Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Adapalene Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Adapalene Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adapalene Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Adapalene Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Adapalene Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adapalene Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adapalene Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adapalene Drugs Tier 1, Tier 2, and Tier 3
4 Adapalene Drugs Market by Type
  1. 4.1 Adapalene Drugs Type Introduction
  2. 4.1.1 Gel
  3. 4.1.2 Solution
  4. 4.1.3 Cream
  5. 4.1.4 Others
  6. 4.2 Global Adapalene Drugs Sales by Type
  7. 4.2.1 Global Adapalene Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Adapalene Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Adapalene Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Adapalene Drugs Revenue by Type
  11. 4.3.1 Global Adapalene Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Adapalene Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Adapalene Drugs Revenue Market Share by Type (2021-2032)
5 Adapalene Drugs Market by Application
  1. 5.1 Adapalene Drugs Application Introduction
  2. 5.1.1 Acne
  3. 5.1.2 Keratosis Pilaris
  4. 5.1.3 Others
  5. 5.2 Global Adapalene Drugs Sales by Application
  6. 5.2.1 Global Adapalene Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Adapalene Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Adapalene Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Adapalene Drugs Revenue by Application
  10. 5.3.1 Global Adapalene Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Adapalene Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Adapalene Drugs Revenue Market Share by Application (2021-2032)
6 Global Adapalene Drugs Sales by Region
  1. 6.1 Global Adapalene Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Adapalene Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Adapalene Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Adapalene Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Adapalene Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Adapalene Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Adapalene Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Adapalene Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Adapalene Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Adapalene Drugs Revenue by Region
  1. 7.1 Global Adapalene Drugs Revenue by Region
  2. 7.1.1 Global Adapalene Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Adapalene Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Adapalene Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Adapalene Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Adapalene Drugs Revenue (2021-2032)
  8. 7.2.2 North America Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Adapalene Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Adapalene Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Adapalene Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Adapalene Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Nuoan Pharmaceutical
  2. 8.1.1 Wuhan Nuoan Pharmaceutical Company Information
  3. 8.1.2 Wuhan Nuoan Pharmaceutical Business Overview
  4. 8.1.3 Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Nuoan Pharmaceutical Adapalene Drugs Product Portfolio
  6. 8.1.5 Wuhan Nuoan Pharmaceutical Recent Developments
  7. 8.2 Sichuan Med-Shine Pharmaceutical
  8. 8.2.1 Sichuan Med-Shine Pharmaceutical Company Information
  9. 8.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product Portfolio
  12. 8.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  13. 8.3 Jiangsu Fubang Pharmaceutical
  14. 8.3.1 Jiangsu Fubang Pharmaceutical Company Information
  15. 8.3.2 Jiangsu Fubang Pharmaceutical Business Overview
  16. 8.3.3 Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Fubang Pharmaceutical Adapalene Drugs Product Portfolio
  18. 8.3.5 Jiangsu Fubang Pharmaceutical Recent Developments
  19. 8.4 Heilongjiang Fuhe Pharmaceutical
  20. 8.4.1 Heilongjiang Fuhe Pharmaceutical Company Information
  21. 8.4.2 Heilongjiang Fuhe Pharmaceutical Business Overview
  22. 8.4.3 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product Portfolio
  24. 8.4.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
  25. 8.5 HEC Pharm
  26. 8.5.1 HEC Pharm Company Information
  27. 8.5.2 HEC Pharm Business Overview
  28. 8.5.3 HEC Pharm Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HEC Pharm Adapalene Drugs Product Portfolio
  30. 8.5.5 HEC Pharm Recent Developments
  31. 8.6 Beijing Foyou Pharmaceutical
  32. 8.6.1 Beijing Foyou Pharmaceutical Company Information
  33. 8.6.2 Beijing Foyou Pharmaceutical Business Overview
  34. 8.6.3 Beijing Foyou Pharmaceutical Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Foyou Pharmaceutical Adapalene Drugs Product Portfolio
  36. 8.6.5 Beijing Foyou Pharmaceutical Recent Developments
  37. 8.7 Taro Pharmaceutical
  38. 8.7.1 Taro Pharmaceutical Company Information
  39. 8.7.2 Taro Pharmaceutical Business Overview
  40. 8.7.3 Taro Pharmaceutical Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Taro Pharmaceutical Adapalene Drugs Product Portfolio
  42. 8.7.5 Taro Pharmaceutical Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz Adapalene Drugs Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
  49. 8.9 Glenmark
  50. 8.9.1 Glenmark Company Information
  51. 8.9.2 Glenmark Business Overview
  52. 8.9.3 Glenmark Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Glenmark Adapalene Drugs Product Portfolio
  54. 8.9.5 Glenmark Recent Developments
  55. 8.10 Galderma
  56. 8.10.1 Galderma Company Information
  57. 8.10.2 Galderma Business Overview
  58. 8.10.3 Galderma Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Galderma Adapalene Drugs Product Portfolio
  60. 8.10.5 Galderma Recent Developments
  61. 8.11 Encube Ethicals
  62. 8.11.1 Encube Ethicals Company Information
  63. 8.11.2 Encube Ethicals Business Overview
  64. 8.11.3 Encube Ethicals Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Encube Ethicals Adapalene Drugs Product Portfolio
  66. 8.11.5 Encube Ethicals Recent Developments
  67. 8.12 Bausch Health
  68. 8.12.1 Bausch Health Company Information
  69. 8.12.2 Bausch Health Business Overview
  70. 8.12.3 Bausch Health Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bausch Health Adapalene Drugs Product Portfolio
  72. 8.12.5 Bausch Health Recent Developments
  73. 8.13 Alembic
  74. 8.13.1 Alembic Company Information
  75. 8.13.2 Alembic Business Overview
  76. 8.13.3 Alembic Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Alembic Adapalene Drugs Product Portfolio
  78. 8.13.5 Alembic Recent Developments
  79. 8.14 Actavis
  80. 8.14.1 Actavis Company Information
  81. 8.14.2 Actavis Business Overview
  82. 8.14.3 Actavis Adapalene Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Actavis Adapalene Drugs Product Portfolio
  84. 8.14.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Adapalene Drugs Value Chain Analysis
  2. 9.1.1 Adapalene Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Adapalene Drugs Production Mode & Process
  6. 9.2 Adapalene Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Adapalene Drugs Distributors
  9. 9.2.3 Adapalene Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst